Syndax Pharmaceuticals, Inc. Other Nonoperating Expense
Syndax Pharmaceuticals, Inc. (SNDX) reported Other Nonoperating Expense of $586.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2025-08-04
- Syndax Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2025-06-30 was $586.00K, a 581.40% increase year-over-year.
- Syndax Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2025-03-31 was $221.00K, a 154.02% increase year-over-year.
- Syndax Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2024-06-30 was $86.00K.
- Syndax Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2024-03-31 was $87.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month |
|---|---|---|
| 2025-06-30 | $586.00K 10-Q · filed 2025-08-04 | $807.00K 10-Q · filed 2025-08-04 |
| 2025-03-31 | $221.00K 10-Q · filed 2025-05-05 | |
| 2024-06-30 | $86.00K 10-Q · filed 2025-08-04 | $173.00K 10-Q · filed 2025-08-04 |
| 2024-03-31 | $87.00K 10-Q · filed 2025-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |